Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / Fortrea appoints Jason Knoblauch CFO
Business CFO appointment

Fortrea appoints Jason Knoblauch CFO

Analysis based on 6 articles · First reported Jun 26, 2026 · Last updated Jun 26, 2026

Sentiment
20
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of Jason Knoblauch as CFO of Fortrea is generally viewed positively, as he brings extensive experience in the drug development landscape. The reiteration of Fortrea's 2026 financial guidance provides stability and confidence to investors, suggesting a steady outlook for the company's performance.

Pharmaceuticals Biotechnology Contract Research
Event Summary

Fortrea, a global contract research organization, announced the appointment of Jason Knoblauch as its new Chief Financial Officer, effective July 6, 2026. He will succeed Jackson McConnell, who is stepping down after contributing significantly to Fortrea's establishment as an independent CRO. Jason Knoblauch brings a wealth of experience from previous CFO roles at Clarios and Roman Curia, and financial leadership at PPD, Inc. (PPD), including its IPO in 2020. Fortrea's CEO, Anshul Thakral, expressed enthusiasm for Jason Knoblauch's leadership in driving the company's growth strategy. Additionally, Fortrea reiterated its financial guidance for the full year 2026, targeting revenues between $2,550 million and $2,650 million and adjusted EBITDA between $190 million and $220 million.

Entities Involved
stock
Fortrea
Fortrea appointed Jason Knoblauch as its new CFO, succeeding Jackson McConnell. The company also reiterated its 2026 financial guidance, indicating stability and a focus on growth.
Importance 100.0 Sentiment 20.0
per
Jason Knoblauch
Jason Knoblauch was appointed as the new Chief Financial Officer of Fortrea, effective July 6, 2026. His experience in global organizations and the drug development landscape is expected to contribute to Fortrea's strategic journey and growth.
Importance 90.0 Sentiment 30.0
per
Jackson McConnell
Jackson McConnell is stepping down as CFO of Fortrea after successfully helping the company become an independent global CRO. She is committed to ensuring a smooth transition for her successor.
Importance 60.0 Sentiment 10.0
priv
Clarios
Jason Knoblauch previously served as CFO at Clarios, a provider of endpoint data solutions to the clinical trials industry, before joining Fortrea.
Importance 20.0 Sentiment 0.0
oth
Roman Curia
Jason Knoblauch previously served as CFO at Roman Curia, a global contract research, development and manufacturing organization, before joining Fortrea.
Importance 20.0 Sentiment 0.0
priv
PPD, Inc.
Jason Knoblauch held various financial leadership roles at PPD, Inc. (PPD), including interim CFO, and was part of the team that led PPD to a successful IPO in 2020.
Importance 20.0 Sentiment 0.0
priv
PwC
Jason Knoblauch previously worked as a director in PwC' (PwC's) Transaction Services practice earlier in his career.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.